Metformina Tevagen

Metformin, the active ingredient in Metformina Tevagen, is a biguanide presented as a unknown/unknown for oral use. It treats type 2 diabetes mellitus and is also used off‑label for gestational diabetes and polycystic ovary syndrome in appropriate patients.

GNH USA supplies Metformina Tevagen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin is an oral antidiabetic agent used to improve glycaemic control in several metabolic conditions.

- Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose and reduces HbA1c. - Gestational diabetes (off‑label): helps maintain maternal glucose levels within target ranges. - Polycystic ovary syndrome (off‑label): may improve insulin resistance and regularise menstrual cycles.

Metformin is associated with a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite. - Diarrhea: loose stools occurring especially after treatment initiation. - Metallic taste: transient alteration in taste perception. - Decreased vitamin B12 levels: may develop with long‑term therapy.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening metabolic disturbance. - Severe hypoglycaemia: usually when combined with insulin or secretagogues. - Hepatic dysfunction: elevated liver enzymes or hepatic failure. - Skin reactions: rash, urticaria, or Stevens‑Johnson syndrome. - Pancreatitis: inflammation of the pancreas reported in isolated cases. - Anemia: due to reduced red blood cell production.

Before initiating Metformina Tevagen, clinicians should consider several safety factors.

- Monitor renal function: adjust or discontinue in moderate to severe renal impairment. - Assess hepatic status: avoid in patients with significant liver disease. - Evaluate risk of lactic acidosis: contraindicated in hypoxia, heart failure, or severe infection. - Review concomitant alcohol use: excessive intake increases acidosis risk. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Metformina Tevagen can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast media: may precipitate lactic acidosis. - Cimetidine: can increase metformin plasma concentrations. - Alcohol abuse: heightens risk of metabolic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycaemia. - Thiazide diuretics: can attenuate glucose‑lowering effect. - ACE inhibitors: require renal function monitoring when combined. - NSAIDs: may impair renal clearance of metformin.